New HIV drug classes on the horizon

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature reviews. Drug discovery

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/NRD2294PMID 17457997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Inhibitory potential of α-amyrin from Calotropis procera against HIV-1 reverse transcriptase: insights from in silico and in vitro assays

  2025cites this paper
• Naturally Occurring Herbs and their Bioactive Metabolites: Potential Targets and Signaling Pathways of Antiviral Agents.

  2023cites this paper
• Burgeoning therapeutic strategies to curb the contemporary surging viral infections.

  2023cites this paper
• Revealing the Mutation Patterns of Drug-Resistant Reverse Transcriptase Variants of Human Immunodeficiency Virus through Proteochemometric Modeling

  2021cites this paper
• The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins (apple seeds) in the Management of Viral Diseases like Corona

  2020cites this paper
• The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases

  2019cites this paper
• Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening

  2018influential citation
• Multivalent Antimicrobial Polymer Nanoparticles Target Mycobacteria and Gram-Negative Bacteria by Distinct Mechanisms

  2017cites this paper
• Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy

  2016cites this paper
• HIV-1: identification of a pathway for virus release and development of a new nanotechnological strategy to counteract the infection

  2014cites this paper
• Quantitative Structure Activity Relationship (qsar) Studies of some Phthalimide Analogues as Hiv-1 Integrase Inhibitors by Heuristic Method

  2014cites this paper
• Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface

  2013cites this paper
• Targeting host factors to circumvent anti-malarial drug resistance.

  2012cites this paper
• Perspectives in HIV Vaccine Development: What we have Learned and how we Proceed Forward

  2012cites this paper
• Modeling anti-HIV compounds: the role of analogue-based approaches.

  2012cites this paper
• Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era

  2012cites this paper
• Rhodium(II) acetate-catalyzed stereoselective synthesis, SAR and anti-HIV activity of novel oxindoles bearing cyclopropane ring.

  2011cites this paper
• QSAR modeling of the inhibition of reverse transcriptase enzyme with benzimidazolone analogs

  2011cites this paper
• Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview.

  2010cites this paper
• Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance: results from the Division of Infectious Diseases, UNIFESP.

  2009cites this paper
• Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.

  2009cites this paper
• Maraviroc and raltegravir.

  2009cites this paper
• Imp roved synthesis of raltegravir

  2009cites this paper
• Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.

  2009cites this paper
• Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.

  2008cites this paper
• Host-Directed Drug Targeting of Factors Hijacked by Pathogens

  2008cites this paper
• Model-based anti-HIV therapy

  2007influential citation
• Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.

  2007cites this paper
• Bioinformatics prediction of HIV coreceptor usage

  2007cites this paper
• Viral infectious disease and natural products with antiviral activity.

  2007cites this paper